|
|
|
Treatment for Colorectal Cancer
August 01, 2006
The pharmaceutical company Roche, has reported that XELOX-a chemotherapy combination of Xeloda plus oxaliplatin-has the same effect on the amount of time colorectal cancer patients live without the cancer progressing as FOLOX-a combination of infused 5-fluorouracil/leucovorin plus oxaliplatin.
|
|
|